HSBC Holdings
SCMP

HSBC Holdings’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

HSBC Holdings’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-443,948
Closed -$7.97M – 2651
2017
Q4 		$7.97M Buy
+443,948
New +$5.47M 0.01% 735

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

HSBC Holdings's SCMP Position: Q1 2018 in Review

HSBC Holdings sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 443,948 shares — an estimated $7.97M sold.

HSBC Holdings first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $7.97M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • HSBC Holdings reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • HSBC Holdings sold 443,948 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $7.97M.
  • HSBC Holdings first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • HSBC Holdings's Sucampo Pharmaceuticals, Inc. position peaked at $7.97M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on HSBC Holdings's 13F filing for Q1 2018, filed 11 May 2018.